Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLA2G4B | P0C869 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 5/20 | 0.43 |
| ▸ | NPC1 | O15118 | 3/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.43 |
| ▸ | NFKB1 | P19838 | 3/20 | 0.43 |
| ▸ | NFKB2 | Q00653 | 3/20 | 0.43 |
| ▸ | RELA | Q04206 | 3/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | THRA | P10827 | 1/20 | 0.39 |
| ▸ | THRB | P10828 | 1/20 | 0.39 |
| ▸ | RARB | P10826 | 3/20 | 0.39 |
| ▸ | MAPT | P10636 | 4/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.38 |
| ▸ | ACR | P10323 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29382893 | 0.93 | PLA2G4B (0.52) | PLA2G4BLMNANPC1SMN1; SMN2NFKB1 | |
| SCHEMBL8924412 | 0.93 | PLA2G4B (0.52) | PLA2G4BLMNANPC1SMN1; SMN2NFKB1 | |
| SCHEMBL4270500 | 0.93 | PLA2G4B (0.52) | PLA2G4BLMNANPC1SMN1; SMN2NFKB1 | |
| SCHEMBL7167527 | 0.89 | PLA2G4B (0.53) | PLA2G4BLMNANPC1SMN1; SMN2NFKB1 | |
| SCHEMBL8926782 | 0.89 | PLA2G4B (0.53) | PLA2G4BLMNANPC1SMN1; SMN2NFKB1 | |
| SCHEMBL4276574 | 0.88 | PLA2G4B (0.45) | PLA2G4BLMNANPC1SMN1; SMN2NFKB1 | |
| SCHEMBL3272113 | 0.88 | PLA2G4B (0.45) | PLA2G4BLMNANPC1SMN1; SMN2NFKB1 | |
| SCHEMBL4271615 | 0.87 | PLA2G4B (0.46) | PLA2G4BLMNANPC1SMN1; SMN2NFKB1 | |
| SCHEMBL7171414 | 0.86 | PLA2G4B (0.44) | PLA2G4BLMNANPC1SMN1; SMN2NFKB1 | |
| SCHEMBL3273651 | 0.85 | PLA2G4B (0.48) | PLA2G4BLMNANPC1SMN1; SMN2NFKB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7935395-B2 | Liquid crystal molecule, liquid crystal display device and liquid crystal optical spatial modulation device | SONY CORPORATION (JP) | 2011-05-03 | — | — | US | disclosed |
| US-20100085530-A1 | LIQUID CRYSTAL MOLECULE, LIQUID CRYSTAL DISPLAY DEVICE AND LIQUID CRYSTAL OPTICAL SPATIAL MODULATION DEVICE | SONY CORPORATION (JP) | 2010-04-08 | — | — | US | disclosed |
| US-7615165-B2 | Liquid crystal molecule, liquid crystal display and liquid crystal optical spatial modulation device | SONY CORPORATION (JP) | 2009-11-10 | — | — | US | disclosed |
| EP-1935961-A1 | Liquid crystal molecule, liquid crystal display device and liquid crystal optical spatial modulation device | Sony Corporation (JP) | 2008-06-25 | — | — | EP | disclosed |
| US-20080143950-A1 | LIQUID CRYSTAL MOLECULE, LIQUID CRYSTAL DISPLAY DEVICE AND LIQUID CRYSTAL OPTICAL SPATIAL MODULATION DEVICE | SONY CORPORATION (JP) | 2008-06-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100085530-A1 | LIQUID CRYSTAL MOLECULE, LIQUID CRYSTAL DISPLAY DEVICE AND LIQUID CRYSTAL OPTICAL SPATIAL MODULATION DEVICE | CXCR1, CXCR5, CXCR2 | PLA2G4B 2161/4885LMNA 2788/4885NPC1 2781/4885 |
| US-20080143950-A1 | LIQUID CRYSTAL MOLECULE, LIQUID CRYSTAL DISPLAY DEVICE AND LIQUID CRYSTAL OPTICAL SPATIAL MODULATION DEVICE | DVL1, CXCR1, LASP1 | PLA2G4B 2566/4885LMNA 4139/4885NPC1 3291/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.